下蒂脂肪皮瓣联合乳房固定术的即刻假体乳房重建经验
该研究回顾2015年6月至2019年3月间65例患者(125侧乳房)的保乳头乳房切除联合乳房固定术及即刻假体植入重建,其中23%假体置于胸肌前、77%置于胸肌后,72%使用脱细胞真皮基质,部分乳头乳晕坏死率9%,中位随访17个月。
要点
- 保乳头乳房切除联合乳房固定术与即刻假体重建可用于乳房下垂和/或巨乳症患者。
- 部分乳头乳晕坏死发生率为9%,部分皮瓣坏死为12%,假体暴露为4%。
- 早期取出率为7%,高于预期,但研究后期已改善。
核心结论
- 保乳头乳房切除联合乳房固定术及即刻假体植入重建显著改善了作者基于假体的乳房重建效果,并将保乳头乳房切除及即刻假体重建的适应证扩展至乳房下垂和/或巨乳症女性。
研究设计与样本
- 回顾性分析2015年6月至2019年3月期间所有行即刻假体乳房重建联合保乳头乳房固定术的病例,共65例患者、125侧乳房重建。
主要发现
- 65例患者(125侧乳房重建)中,15例(23%)假体置于胸肌前,50例(77%)置于胸肌后。
- 47例患者(72%)使用了脱细胞真皮基质。
- 6例患者(9%)发生部分乳头乳晕复合体坏死。
- 其他并发症包括部分乳房切除皮瓣坏死(8例患者,12%)、假体暴露(3例,4%)、感染(1例,1%)、包膜挛缩(4例,6%)和再手术(11例,16%)。
- 平均随访17个月(范围3至47个月),截至数据收集时未见癌症复发报告。
关键数值与推荐
- 部分乳头乳晕复合体坏死发生率为9%(6例患者)。
- 部分乳房切除皮瓣坏死发生率为12%(8例患者)。
- 假体暴露发生率为4%(3例)。
- 感染发生率为1%(1例)。
- 包膜挛缩发生率为6%(4例)。
临床怎么用
- 对于乳房下垂和/或巨乳症患者,可考虑采用下蒂脂肪皮瓣维持乳头乳晕复合体血供的保乳头乳房切除联合乳房固定术及即刻假体植入重建。
- 需注意部分乳头乳晕坏死、皮瓣坏死及假体暴露等并发症风险,并关注早期取出率。
局限性
- 本研究为回顾性分析,证据等级为治疗性IV级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Direct-to-implant breast reconstruction continues to grow in popularity among reconstructive breast surgeons and patients alike. Women with large breasts and ptosis are often thought not to be candidates for nipple sparing or direct-to-implant reconstruction. The authors utilized a single-stage, nipple-sparing, direct-to-implant reconstruction with simultaneous mastopexy, while the nipple-areolar complex was kept viable on an inferiorly based adipodermal flap in a single stage. They report their experience and outcomes using this approach in women with breast ptosis and/or macromastia. METHODS: The authors reviewed all direct-to-implant reconstructions with simultaneous nipple-sparing mastopexies performed from June of 2015 to March of 2019. Sixty-five patients and 125 breast reconstructions were analyzed. RESULTS: Among the 65 patients (125 breast reconstructions), 15 (23 percent) had implants placed in the prepectoral space, and 50 (77 percent) had them placed subpectorally. Forty-seven patients (72 percent) had acellular dermal matrix used. Partial nipple-areolar complex necrosis occurred in six patients (9 percent). Other complications included partial mastectomy flap necrosis (n = 8 patients, 12 percent), implant exposure (n = 3, 4 percent), infection (n = 1, 1 percent), capsular contracture (n = 4, 6 percent), and reoperation (n = 11, 16 percent). Mean follow-up was 17 months (range, 3 to 47 months). There have been no cancer recurrences reported in any participants to date. CONCLUSIONS: Nipple-sparing mastectomy with mastopexy and immediate direct-to-implant reconstruction dramatically improved the authors' results for implant-based breast reconstruction patients. The higher than expected explantation rate of 7 percent early in the study has since improved. This approach provides an opportunity to expand indications for nipple-sparing mastectomy and direct-to-implant reconstruction to women with breast ptosis and/or macromastia. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
引用
- Mosharrafa AM, Mosharrafa TM, Zannis VJ, et al. Direct-to-Implant Breast Reconstruction with Simultaneous Nipple-Sparing Mastopexy Utilizing an Inferiorly Based Adipodermal Flap: Our Experience with Prepectoral and Subpectoral Techniques. Plast Reconstr Surg. 2020. PMID: 32332524. doi:10.1097/PRS.0000000000006781
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。